Clinical Trials Logo

Esophagogastroduodenoscopy clinical trials

View clinical trials related to Esophagogastroduodenoscopy.

Filter by:

NCT ID: NCT05504434 Completed - Gastroscopy Clinical Trials

Performance of a Single-use Gastroscope (aScope Gastro) for Esophagogastroduodenoscopy

FARE
Start date: July 4, 2022
Phase: N/A
Study type: Interventional

Several infectious outbreaks have been described in the literature as a result of contaminated endoscopes. These endoscopes cannot be sterilized and require an extensive cleaning process in which breaches of cleaning protocols, endoscope damage or the formation of biofilm can prevent proper disinfection. The risk of endoscopy associated infection (EAI) and colonization due to contaminated endoscopes is still considered to be low. However, it is likely that there is severe underreporting of outbreaks due to a lack of recognition or assuming an infection to be endogenous. Due to the sheer volume of upper-gastrointestinal endoscopy worldwide, even with a low risk of EAI, the number of affected patients is significant. In response, several manufacturers have turned to the production of single-use endoscopes that eliminate the risk of exogenous infections. There are single use duodenoscopes on the market that almost seem to match the performance of reusable duodenoscopes. A new single use sterile gastroscope, Ambu aScope gastro, has been developed whose performance has not been previously described in patients. This multicenter single arm consecutive case series study will test the performance of these single use gastroscopes in patients undergoing esophagogastroduodenoscopy.

NCT ID: NCT05407870 Recruiting - Clinical trials for Sedation Complication

Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection

Start date: June 9, 2022
Phase: N/A
Study type: Interventional

During endoscopy, the patient is sedated to relieve pain and improve the ease of the procedure. Sedation endoscopy using propofol is effective, but has the disadvantage that cardiopulmonary side effects are frequently observed. However, etomidate is known to have hemodynamic and respiratory stability.The purpose of this study was to compare the efficacy and safety of etomidate and propofol in sedated gastric endoscopic submucosal dissection.

NCT ID: NCT04725695 Enrolling by invitation - Anesthetics, Local Clinical Trials

Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

LIDOGAS
Start date: March 29, 2022
Phase: Phase 4
Study type: Interventional

In this randomized placebo-controlled clinical trial, patients will be randomized to be administered viscous lidocaine or placebo preoperatively to elective upper GI endoscopy

NCT ID: NCT04720924 Completed - Clinical trials for Esophagogastroduodenoscopy

AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract

Start date: January 16, 2021
Phase: N/A
Study type: Interventional

The purpose of our study was to assess the performance of esophagogastroduodenoscopy automatic quality-control system in real-time quality control of EGD.

NCT ID: NCT04247399 Completed - Education Clinical Trials

Simulation-assisted Teaching in Learning Gastroscopy

Start date: February 15, 2020
Phase: N/A
Study type: Interventional

This project is a single-blinded randomized controlled trial investigating the effect of simulation-based teaching in learning gastroscopy for medical doctors.

NCT ID: NCT04168294 Terminated - Cognition Disorders Clinical Trials

The Influence of Sedation for Endoscopy on Cognitive Function

Start date: November 14, 2019
Phase:
Study type: Observational

It is commonly recommended that patients should refrain from driving for 24 hours after sedation for endoscopy,however,this recommendation has been queried recently.To investigate the effect of sedation on early postoperative cognitive function in patients undergoing endoscopy.

NCT ID: NCT03883035 Completed - Clinical trials for Esophagogastroduodenoscopy

Quality Control of Esophagogastroduodenoscopy Using Real-time EGD Auxiliary System

Start date: March 20, 2019
Phase: N/A
Study type: Interventional

The aim of our study was to develop an automatic quality-control system and assess the performance of this system in quality control of esophagogastroduodenoscopy.

NCT ID: NCT03070379 Recruiting - Clinical trials for Esophagogastroduodenoscopy

Topical Pharyngeal Anesthesia in Sedated Esophagogastroduodenoscopy

Start date: February 20, 2017
Phase: N/A
Study type: Interventional

At recent, the number of patients who underwent sedated esophagogastroduodenoscopy has been on the increase. For such patients, whether topical pharyngeal anesthesia is needed remains to be controversial. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline for non-anesthesiologist administration of propofol for GI endoscopy have not made any recommendation, because the role of pharyngeal anesthesia during propofol sedation for upper digestive endoscopy has not been assessed. Our study aimed at investigating whether topical lidocaine pharyngeal anesthesia could benefit patients who underwent esophagogastroduodenoscopy under propofol sedation.

NCT ID: NCT02264249 Active, not recruiting - Colonoscopy Clinical Trials

Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation

Start date: September 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine residual gastric volume and residual gastric pH in patients undergoing combined EGD and colonoscopy comparing the standard single dose prep with the split dose bowel preparation and same day bowel preparations.

NCT ID: NCT02215291 Completed - Clinical trials for Esophagogastroduodenoscopy

NvisionVLE™ Registry System Registry

Start date: July 2014
Phase:
Study type: Observational [Patient Registry]

Prospective, multi-site registry with longitudinal follow up for patients undergoing EGD or endoscopy. The primary objective is to provide a collection of patient NvisionVLE™ procedural data for participating physicians, including, but not limited to, imaging data, clinical utility data, demographics, pathology, treatment, and surveillance.